EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The clinical relevance of MOG antibody testing in cerebrospinal fluid

Molly Reynolds, Irene Tan, Kristy Nguyen, Vera Merheb, Fiona X Z Lee, Benjamin P Trewin iD, Magdalena Lerch, Snehal Shah, Nigel Wolfe, Katherine Buzzard, Jeannette Lechner-Scott, Marzena Fabis-Pedrini und 11 weitere

Annals of Clinical and Translational Neurology · 2024-09 · 11 (9) · 2514-2519

DOI: 10.1002/acn3.52163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 28.07.2024. Verfasst von Molly Reynolds und 22 weiteren Autor:innen. Beteiligte Einrichtung: Translational Neuroimmunology Group, Kids Neuroscience Centre, Faculty of Medicine and Health, University of Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Myelin-Oligodendrocyte Glycoprotein, Autoantibodies. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Royal Australasian College of Physicians, Faculty of Medicine and Health, University of Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) is diagnosed by serum MOG‐immunoglobulin G (MOG‐IgG) in association with typical demyelination. 111/1127 patients with paired CSF/serum samples were seropositive for MOG‐IgG. Only 7/1016 (0.7%) seronegative patients had CSF‐restricted MOG‐IgG. While 3/7 patients had longitudinally extensive transverse myelitis, four had a confirmed alternate diagnosis (three multiple sclerosis, one CNS vasculitis). In a national referral setting, CSF‐restricted MOG‐IgG had a low sensitivity (2.63%, 95%CI 0.55–7.50%) and low positive predictive value (1.97%, 95%CI 0.45–8.13%). We strongly recommend serum as the preferred diagnostic biospecimen, and urge caution in the interpretation of CSF‐restricted MOG‐IgG in patients without clinico‐radiological features consistent with MOGAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelin-Oligodendrocyte GlycoproteinAutoantibodiesHumansAdultFemaleMaleMiddle AgedYoung AdultAgedImmunoglobulin GAdolescentMyelitis, TransverseMultiple SclerosisChildClinical Relevance

Substanzen

Myelin-Oligodendrocyte GlycoproteinAutoantibodiesMOG protein, humanImmunoglobulin G

Autor:innen und Institutionen

  • Translational Neuroimmunology Group, Kids Neuroscience Centre, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
  • Department of Neurology, Concord Hospital, Sydney, Australia.
  • Department of Radiology, Concord Hospital, Sydney, Australia.
  • Brain Autoimmunity Group, Kids Neuroscience Centre, Children's Hospital at Westmead, Sydney, Australia.
  • Sydney Medical School and Brain and Mind Centre, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
  • Department of Neurology, Perth Children's Hospital, University of Western Australia, Perth, Australia.

ORCID-Profile: Benjamin P Trewin, Russell C Dale, Fabienne Brilot, Sudarshini Ramanathan

Förderung

  • National Health and Medical Research Council
  • Royal Australasian College of Physicians
  • Faculty of Medicine and Health, University of Sydney

Zitieren

APA

Reynolds, M., Tan, I., Nguyen, K., Merheb, V., Lee, F. X. Z., Trewin, B. P., Lerch, M., Shah, S., Wolfe, N., Buzzard, K., Lechner-Scott, J., Fabis-Pedrini, M., Fok, A., John, N., Kneebone, C., Yiannikas, C., Brown, D. A., Kermode, A. G., Reddel, S., …, & Australasian MOGAD Study Group (2024). The clinical relevance of MOG antibody testing in cerebrospinal fluid. Annals of Clinical and Translational Neurology, 11(9), 2514-2519. https://doi.org/10.1002/acn3.52163

Vancouver

Reynolds M, Tan I, Nguyen K, Merheb V, Lee FXZ, Trewin BP, et al. The clinical relevance of MOG antibody testing in cerebrospinal fluid. Annals of Clinical and Translational Neurology. 2024;11(9):2514-2519. doi:10.1002/acn3.52163

BibTeX
@article{Reynolds2024,
  author = {Reynolds, Molly and Tan, Irene and Nguyen, Kristy and Merheb, Vera and Lee, Fiona X Z and Trewin, Benjamin P and Lerch, Magdalena and Shah, Snehal and Wolfe, Nigel and Buzzard, Katherine and Lechner-Scott, Jeannette and Fabis-Pedrini, Marzena and Fok, Anthony and John, Nevin and Kneebone, Chris and Yiannikas, Con and Brown, David A and Kermode, Allan G and Reddel, Stephen and Dale, Russell C and Brilot, Fabienne and Ramanathan, Sudarshini and Australasian MOGAD Study Group, Australasian MOGAD Study Group},
  title = {The clinical relevance of MOG antibody testing in cerebrospinal fluid},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  volume = {11},
  number = {9},
  pages = {2514--2519},
  doi = {10.1002/acn3.52163}
}
Kostenlos starten →